Toward Type I/II ROS Generation Photoimmunotherapy by Molecular Engineering of Semiconducting Perylene Diimide
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202303175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Jie Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Strait Laboratory of Flexible Electronics (SLoFE), Strait Institute of Flexible Electronics (SIFE, Future Technologies), Fujian Normal University, Fu…. Hauptthemen laut MEDLINE: Perylene, Nanoparticles, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation team of Photoelectric functional materials and devices for biomedical theranostics of Fujian Normal University, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
As prospective phototheranostic agents for cancer imaging and therapy, semiconducting organic molecule‐based nanomedicines are developed. However, near‐infrared (NIR) emission, and tunable type I (O 2 • − ) and type II ( 1 O 2 ) photoinduced reactive oxygen species (ROS) generation to boost cancer photoimmunotherapy remains a big challenge. Herein, a series of D–π–A structures, NIR absorbing perylene diimides (PDIs) with heavy atom bromide modification at the bay position of PDIs are prepared for investigating the optimal photoinduced type I/II ROS generation. The heavy atom effect has demonstrated a reduction of molecular ∆ E ST and promotion of the intersystem crossing processes of PDIs, enhancing the photodynamic therapy (PDT) efficacy. The modification of three bromides and one pyrrolidine at the bay position of PDI (TBDT) has demonstrated the best type I/II PDT performance by batch experiments and theoretical calculations. TBDT based nanoplatforms (TBDT NPs) enable type I/II PDT in the hypoxic tumor microenvironment as a strong immunogenic cell death (ICD) inducer. Moreover, TBDT NPs showing NIR emission allow in vivo bioimaging guided phototherapy of tumor. This work uses novel PDIs with adjustable type I/II ROS production to promote antitumor immune response and accomplish effective tumor eradication, consequently offering molecular guidelines for building high‐efficiency ICD inducers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Strait Laboratory of Flexible Electronics (SLoFE), Strait Institute of Flexible Electronics (SIFE, Future Technologies), Fujian Normal University, Fuzhou, Fujian, 350117, P. R. China.
- State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
- Frontiers Science Center for Flexible Electronics (FSCFE), MIIT Key Laboratory of Flexible Electronics (KLoFE), Northwestern Polytechnical University, Xi'an, 710072, P. R. China.
ORCID-Profile: Wei Huang
Förderung
- National Natural Science Foundation of China
- Innovation team of Photoelectric functional materials and devices for biomedical theranostics of Fujian Normal University
- Natural Science Foundation of Fujian Province
Zitieren
APA
Zhang, J., Ma, W., Luo, H., Zhang, K., Lv, J., Jiang, L., Huang, Y., Song, J., Yang, Z., & Huang, W. (2024). Toward Type I/II ROS Generation Photoimmunotherapy by Molecular Engineering of Semiconducting Perylene Diimide. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303175
Vancouver
Zhang J, Ma W, Luo H, Zhang K, Lv J, Jiang L, et al. Toward Type I/II ROS Generation Photoimmunotherapy by Molecular Engineering of Semiconducting Perylene Diimide. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303175
BibTeX
@article{Zhang2024,
author = {Zhang, Jie and Ma, Wen and Luo, Haifen and Zhang, Kangxin and Lv, Jingqi and Jiang, Lizhi and Huang, Yanli and Song, Jibing and Yang, Zhen and Huang, Wei},
title = {Toward Type I/II ROS Generation Photoimmunotherapy by Molecular Engineering of Semiconducting Perylene Diimide},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202303175}
}
EUVIMED